Results 121 to 130 of about 3,468 (199)
JOR SPINE, Volume 9, Issue 3, September 2026.From preclinical promise to clinical translation in intervertebral disc degeneration (IDD). Robust preclinical evidence supports a range of biologic therapies, with consistent improvements in imaging, extracellular matrix composition, inflammation, and behavior.
Luca Ambrosio +5 more
wiley +1 more source
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.A case series studying outcomes up to 18 months in autistic patients from the UK Medical Cannabis Registry. ABSTRACT Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with distressed behaviors and psychological challenges.
Arushika Aggarwal +17 more
wiley +1 more source
EuroQol Study of the Elderly General Population
Iryo To Shakai, 2000 Shigeki Nawata +3 more
openaire +3 more sources
United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.ABSTRACT Background Functional dyspepsia (FD) is a prevalent disorder of gut‐brain interaction (DGBI) and is associated with substantial impact on health care utilisation. However, analyses examining patient‐specific characteristics that contribute to this burden remain limited.
Daan H. C. A. Bosch +6 more
wiley +1 more source
Impaired Pre‐Critical Illness Quality of Life in Elderly ICU Patients
Acta Anaesthesiologica Scandinavica, Volume 70, Issue 8, September 2026.ABSTRACT Background The EuroQol EQ‐5D‐5L is recommended to assess health‐related quality of life (HRQoL) in intensive care unit (ICU) survivors and included in many national ICU registries at the time of follow‐up. While establishing baseline HRQoL in elderly ICU survivors is important for informing follow‐up services, it is rarely performed in ...
Shirin K. Frisvold +8 more
wiley +1 more source
Acta Anaesthesiologica Scandinavica, Volume 70, Issue 8, September 2026.ABSTRACT Background There is limited high‐quality evidence to guide haemodynamic and respiratory management during general anaesthesia. The goal of this trial was to test the feasibility of testing different ventilatory settings and blood pressure targets.
Maria B. Pælestik +38 more
wiley +1 more source
Addiction, Volume 121, Issue 9, Page 2292-2316, September 2026.Abstract Background and aims Measurement‐based care (MBC) is a structured approach using standardized, repeated assessments to monitor treatment progress and guide clinical decision‐making. MBC improves outcomes for substance use treatment but can be time consuming due in part to lengthy assessment tools. Single‐item, patient‐reported outcome measures (
Thomas J. Reese +13 more
wiley +1 more source
Addiction, Volume 121, Issue 9, Page 2433-2449, September 2026.Abstract Background and aims Mindfulness‐based relapse prevention (MBRP) has been shown to be beneficial to individuals with substance use disorder (SUD) in the West. The current pilot study aimed at testing the feasibility of MBRP in a Chinese population.
Ka Tsun Ting +11 more
wiley +1 more source
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background and Aims Small fiber neuropathy (SFN) is a peripheral neuropathy causing neuropathic pain, reduced quality of life (QoL), and high societal costs. Previous studies assessed these societal costs before a definitive diagnosis was established, leaving it unclear whether diagnostic confirmation affects costs, pain intensity, or QoL ...
Dennis Kool +7 more
wiley +1 more source
Journal of Renal Care, Volume 52, Issue 3, September 2026.ABSTRACT Background Patient‐reported outcome measures can highlight the impact of kidney failure and kidney replacement therapy on a person's health‐related quality of life and symptom burden. But their implementation is limited and heterogeneous within Australian and New Zealand kidney care.
Jessica Nikolovski +10 more
wiley +1 more source